Status:
UNKNOWN
Nefopam Versus Ondansteron for Prevention of Post Spinal Shivering.
Lead Sponsor:
Saint-Joseph University
Conditions:
Shivering
Adverse Effects in the Therapeutic Use of Anaesthetic
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
Spinal anesthesia affects the homeostatic systems resulting in intraoperative hypothermia and subsequently shivering. In fact, shivering may be seen after this technique in 30 to 40% of cases . Ondans...
Eligibility Criteria
Inclusion
- age between 18 and 65 years
- scheduled for a surgery under spinal anesthesia
Exclusion
- pregnant or breastfeeding (for the women), if they are
- Allergy to any of the drugs to be used
- Long QT syndrome
- Hepatic insufficiency
- Renal failure
- Parkinson's disease
- Epilepsy
- Glaucoma
- Phenylketonuria
Key Trial Info
Start Date :
December 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2021
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04870541
Start Date
December 1 2020
End Date
December 1 2021
Last Update
May 3 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universite Saint Joseph , Hotel Dieu de France
Beirut, Lebanon